secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2026-06-25T21:00:13+00:00
Accession:  0001193125-26-282989
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics stockholders elect Wilbur Ross and Dieter Weinand as Class I directors, ratify auditor
--------------------------------------------------------------------------------

- Wilbur Ross elected as Class I director with 9,168,496 for, 2,818,233 against, 4,585,732 broker non-votes.
- Dieter Weinand elected with 10,566,702 for, 1,420,027 against, 4,585,732 broker non-votes.
- Ratification of Weaver & Tidwell as independent auditor passed with 16,545,887 for, 22,661 against, 3,913 abstain.
- All proposals passed; no unexpected or contested items at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312526282989/0001193125-26-282989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312526282989/d143621d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-282989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer